ArticleClinical and experimental immunology2014

Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis.

Y-Z Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.